| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2010-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d343d55580c8af8c3776cdd590c0e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7593f84f14f7abc7995b6691617c2b54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b370c81b33b16a885ac6482fbf5673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24bc4c09b6f3ebaa19465d63df336e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f73260cb0c66fae86e4e0376c451ef7e |
| publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2012004908-A |
| titleOfInvention |
METHOD OF DIAGNOSIS TO DETERMINE THE FORECAST OF LUNG CANCER OF NON-SMALL CELLS. |
| abstract |
The present invention provides methods for identifying patients with small cell lung cancer (NSCLC) at an early stage who have an unfavorable prognosis for recurrence of lung cancer after surgical resection. The methods are based in part on the discovery of abnormalities of the number of chromosomal copies that can be used for prognostic classification. The methods preferably utilize in situ fluorescence hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the number of chromosome copies of these genetic sites. |
| priorityDate |
2009-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |